Clinical Trial Update: Ropivacaine 0.2% Pre-Filled Dispenser for the Treatment of Postsurgical Pain in Patients Undergoing Cesarean Delivery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ropivacaine 0.2% pre-filled dispenser for postoperative pain in cesarean delivery completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain After Cesarean Delivery

Drugs mentioned

• Ropivacaine 0.2% pre-filled dispenser (ropivacaine)

Snippet

Sponsor: BioQ Pharma, Inc. | Conditions: Pain, Postoperative | Phase 3 | Status: COMPLETED